Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DINOPROSTONE for Foetal exposure during pregnancy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where DINOPROSTONE was used for Foetal exposure during pregnancy.

Most Reported Side Effects for DINOPROSTONE

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 67 9.3% 3 23
Uterine hyperstimulation 65 9.0% 1 13
Off label use 52 7.2% 1 25
Premature separation of placenta 48 6.6% 0 7
Maternal exposure during pregnancy 46 6.4% 0 25
Postpartum haemorrhage 40 5.5% 7 16
Premature baby 40 5.5% 1 16
Drug ineffective 36 5.0% 0 5
Foetal heart rate deceleration abnormality 36 5.0% 1 8
Premature delivery 33 4.6% 1 14
Exposure during pregnancy 32 4.4% 1 9
Uterine rupture 32 4.4% 1 11
Haemoglobin decreased 31 4.3% 0 14
Uterine hypertonus 31 4.3% 0 10
Foetal exposure during delivery 30 4.2% 3 3

Other Indications for DINOPROSTONE

Labour induction (286) Induction of cervix ripening (182) Product used for unknown indication (154) Induced labour (23) Cervical dilatation (5) Delivery (5)

Other Drugs Used for Foetal exposure during pregnancy

HYDROXYPROGESTERONE CAPROATE (4,042) ONDANSETRON (1,061) ASPIRIN (485) BETAMETHASONE (475) PREDNISONE (429) ACETAMINOPHEN (428) OXYCODONE (414) LEVETIRACETAM (401) TACROLIMUS (382) LAMOTRIGINE (343)

Related Pages

DINOPROSTONE Full Profile All Foetal exposure during pregnancy Drugs DINOPROSTONE Demographics DINOPROSTONE Timeline